搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
2 小时
Looking at 2025, Health: Breakthroughs of hope and promise
Weight-loss treatments are on the cusp of a revolution, and could benefit large numbers of Indians after the main patent ...
5 小时
The Zepbound Shortage Is Over — Here's What to Expect if You've Been Using a Compounding ...
Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand ...
6 小时
‘Ozempic Santa’: Musk Reveals His Use Of Mounjaro In Latest Weight-Loss Drug Endorsement
Tesla chief Elon Musk dubbed himself “Ozempic Santa” in an X post on Christmas Day, marking the tech billionaire’s latest ...
7 小时
Elon Musk Shares Christmas Weight-Loss Post: 'Ozempic Santa'
Elon Musk has admitted to taking a weight-loss drug in a Christmas Day post on X, formerly Twitter, as he shared a picture of ...
9 小时
Weight-loss drugs take over year of 2024: Bloomberg
Seemingly overnight millions of people were taking the medicines known as GLP-1s while blockbuster drugs like Ozempic Wegovy Mounjaro and Zepbou ...
9 小时
Musk Tests Mounjaro, Ozempic, Wegovy: Which Weight-Loss Drug Won Him Over?
Mounjaro and Ozempic are both GLP-1 receptors that can be used to help people with diabetes. The treatments are also ...
10 小时
'What a difference a year makes': Stocks in this sector are set to surge in 2025 after a ...
Citi analysts forecast 19% earnings growth for the healthcare sector in 2025 amid improving fundamentals and a boom in weight ...
Mountain Democrat
10 小时
California Medicaid Spent $1.4B on GLP-1s for Obesity Over the Past 12 Months
Ozempic, Wegovy, and other GLP-1 receptor agonists have become a game-changer in obesity treatment, but their high ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈